Medical Doctor Program year 2021 Reported 2019–2021 Source: CMS Open Payments, 2026 publication

Viola Jacob

General Practice Oviedo, FL Medical Doctor

NPI 1972597193 CMS profile 43812

1451 Haven Dr, Oviedo, FL 32765

Open in the dashboard

General payments

$319

7 records reported · program years 2019–2021

Research payments

$0

Paid to them · None reported · program years 2019–2021

Ownership & investment interest

$0

None reported

Through program year 2021, Viola Jacob of Oviedo, FL is reported in the CMS Open Payments database as having received $319 across 7 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 60th percentile of General Practice profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

2 rows
Year Kind Relative to this record's peak year Amount Records
2021 General $156 3
2019 General $163 4

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Viola Jacob
  • General Practice median
  • Middle half of General Practice
  • National median

In program year 2025, general payments to Viola Jacob were reported at $0. Among 4,774 General Practice profiles paid that year, the median was $106 and the middle half received between $35 and $292.

Show as a table
Year Viola Jacob General Practice median Middle half National median
2019 $163 $107 $37–$285 $163
2020 $0 $75 $25–$213 $114
2021 $156 $93 $30–$272 $132
2022 $0 $103 $36–$279 $149
2023 $0 $106 $34–$276 $160
2024 $0 $114 $39–$290 $164
2025 $0 $106 $35–$292 $169

Breakdown

Who paid General payments · program years 2019–2021
  1. Novartis Pharmaceuticals Corporation $127 2 payments
  2. Genentech USA, Inc. $117 1 payment
  3. Teva Pharmaceuticals USA, Inc. $39 2 payments
  4. Sunovion Pharmaceuticals Inc. $36 2 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2021
  1. Food and Beverage $319 7 payments
Products named General payments · program years 2019–2021
  1. ENTRESTO $127 2 payments
  2. Erivedge $117 1 payment
  3. AUSTEDO $39 2 payments
  4. APTIOM $36 2 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Prescribing to Medicare patients

Part D · data year 2024 · 186 drugs

Part D claims

11,131

Median for Internal Medicine: 777

Drug cost

$712,244

Median for Internal Medicine: $73,373

Branded share of claims

19.4%

Median for Internal Medicine: 19.3%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Eliquis Apixaban Brand 506 $205,850
Jardiance Empagliflozin Brand 102 $46,186
Xarelto Rivaroxaban Brand 87 $36,663
Procrit Epoetin Alfa Brand 27 $32,920
Januvia Sitagliptin Phosphate Brand 49 $32,789
Trulicity Dulaglutide Brand 27 $17,507
Entresto Sacubitril/Valsartan Brand 46 $17,435
Trelegy Ellipta Fluticasone/Umeclidin/Vilanter Brand 21 $16,567
Santyl Collagenase Clostridium Hist. Brand 33 $14,062
Myrbetriq Mirabegron Brand 24 $12,301

The 10 drugs with the highest cost, of 186 counted.

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 104,182 Part D prescribers listed as Internal Medicine; they describe a distribution and say nothing about conduct.

Billing to Medicare

Part B · data year 2024 · 22 billing codes

Paid by Medicare

$271,443

Medicare's payments for the services billed

Medicare patients

341

Average age 83

Services billed

3,676

218 women, 123 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 75%
Arthritis 58%
Depression 55%
Alzheimer's or dementia 53%
Diabetes 50%
Ischemic heart disease 47%
Chronic kidney disease 47%
Heart failure 44%

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

7 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other General Practice in Florida

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2021

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record